PCO-Syndrom.de - Ihre PCOS-Ansprechpartner in Deutschland

Neue Literatur zum Thema PCOS

(Letztes Update: April 2006)

  1. Allemand MC, Tummon IS, Phy JL, Foong SC, Dumesic DA, Session DR 2006 Diagnosis of polycystic ovaries by three-dimensional transvaginal ultrasound. Fertil Steril 85:214-219

  2. Al-Ojaimi EH 2006 Pregnancy outcomes after laparoscopic ovarian drilling in women with polycystic ovarian syndrome. Saudi Med J 27:519-525

  3. Atay V, Cam C, Muhcu M, Cam M, Karateke A 2006 Comparison of letrozole and clomiphene citrate in women with polycystic ovaries undergoing ovarian stimulation. J Int Med Res 34:73-76

  4. Azziz R 2006 Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature. J Clin Endocrinol Metab 91:781-785

  5. Azziz R 2006 Reply: How many of the items in the polycystic ovary syndrome can be validated statistically? Fertil Steril 85:530

  6. Baillargeon JP, Diamanti-Kandarakis E, Ostlund RE, Jr., Apridonidze T, Iuorno MJ, Nestler JE 2006 Altered D-chiro-inositol urinary clearance in women with polycystic ovary syndrome. Diabetes Care 29:300-305

  7. Balen AH, Dresner M, Scott EM, Drife JO 2006 Should obese women with polycystic ovary syndrome receive treatment for infertility? Bmj 332:434-435

  8. Ballian N, Mantoudis E, Kaltsas GA 2006 Pregnancy following ovarian drilling in a woman with polycystic ovary syndrome and nine previous first trimester miscarriages. Arch Gynecol Obstet 273:384-386

  9. Baravalle C, Salvetti NR, Mira GA, Lorente JA, Ortega HH 2006 The role of ACTH in the pathogenesis of polycystic ovarian syndrome in rats: hormonal profiles and ovarian morphology. Physiol Res

  10. Batukan C, Muderris, II 2006 Efficacy of a new oral contraceptive containing drospirenone and ethinyl estradiol in the long-term treatment of hirsutism. Fertil Steril 85:436-440

  11. Boudreaux MY, Talbott EO, Kip KE, Brooks MM, Witchel SF 2006 Risk of T2DM and impaired fasting glucose among PCOS subjects: results of an 8-year follow-up. Curr Diab Rep 6:77-83

  12. Bridger T, MacDonald S, Baltzer F, Rodd C 2006 Randomized placebo-controlled trial of metformin for adolescents with polycystic ovary syndrome. Arch Pediatr Adolesc Med 160:241-246

  13. Cagnacci A, Tirelli A, Renzi A, Paoletti AM, Volpe A 2006 Effects of two different oral contraceptives on homocysteine metabolism in women with polycystic ovary syndrome. Contraception 73:348-351

  14. Carmina E 2006 Metabolic syndrome in polycystic ovary syndrome. Minerva Ginecol 58:109-114

  15. Carmina E, Napoli N, Longo RA, Rini GB, Lobo RA 2006 Metabolic syndrome in polycystic ovary syndrome (PCOS): lower prevalence in southern Italy than in the USA and the influence of criteria for the diagnosis of PCOS. Eur J Endocrinol 154:141-145

  16. Carmina E, Orio F, Palomba S, Longo RA, Cascella T, Colao A, Lombardi G, Rini GB, Lobo RA 2006 Endothelial dysfunction in PCOS: role of obesity and adipose hormones. Am J Med 119:356 e351-356

  17. Cataldo NA, Abbasi F, McLaughlin TL, Basina M, Fechner PY, Giudice LC, Reaven GM 2006 Metabolic and ovarian effects of rosiglitazone treatment for 12 weeks in insulin-resistant women with polycystic ovary syndrome. Hum Reprod 21:109-120

  18. Cattrall FR, Vollenhoven BJ, Weston GC 2005 Anatomical evidence for in utero androgen exposure in women with polycystic ovary syndrome. Fertil Steril 84:1689-1692

  19. Chan CC, Koo MW, Ng EH, Tang OS, Yeung WS, Ho PC 2006 Effects of Chinese green tea on weight, and hormonal and biochemical profiles in obese patients with polycystic ovary syndrome--a randomized placebo-controlled trial. J Soc Gynecol Investig 13:63-68

  20. Codner E, Soto N, Lopez P, Trejo L, Avila A, Eyzaguirre FC, Iniguez G, Cassorla F 2006 Diagnostic Criteria for Polycystic Ovary Syndrome and Ovarian Morphology in Women with Type 1 Diabetes Mellitus. J Clin Endocrinol Metab

  21. Coffey S, Bano G, Mason HD 2006 Health-related quality of life in women with polycystic ovary syndrome: A comparison with the general population using the Polycystic Ovary Syndrome Questionnaire (PCOSQ) and the Short Form-36 (SF-36). Gynecol Endocrinol 22:80-86

  22. Corbould A, Zhao H, Mirzoeva S, Aird F, Dunaif A 2006 Enhanced mitogenic signaling in skeletal muscle of women with polycystic ovary syndrome. Diabetes 55:751-759

  23. Costello MF, Chapman M, Conway U 2006 A systematic review and meta-analysis of randomized controlled trials on metformin co-administration during gonadotrophin ovulation induction or IVF in women with polycystic ovary syndrome. Hum Reprod

  24. Cristello F, Cela V, Artini PG, Genazzani AR 2005 Therapeutic strategies for ovulation induction in infertile women with polycystic ovary syndrome. Gynecol Endocrinol 21:340-352

  25. Cussons AJ, Stuckey BG, Watts GF 2006 Cardiovascular disease in the polycystic ovary syndrome: new insights and perspectives. Atherosclerosis 185:227-239

  26. Dehbashi S, Vafaei H, Parsanezhad MD, Alborzi S 2006 Time of initiation of clomiphene citrate and pregnancy rate in polycystic ovarian syndrome. Int J Gynaecol Obstet 93:44-48

  27. Dewailly D 2006 How many of the items in the polycystic ovary syndrome can be validated statistically? Fertil Steril 85:529; author reply 530

  28. Diamanti-Kandarakis E, Paterakis T, Alexandraki K, Piperi C, Aessopos A, Katsikis I, Katsilambros N, Kreatsas G, Panidis D 2006 Indices of low-grade chronic inflammation in polycystic ovary syndrome and the beneficial effect of metformin. Hum Reprod

  29. Diamanti-Kandarakis E, Piperi C, Alexandraki K, Katsilambros N, Kouroupi E, Papailiou J, Lazaridis S, Koulouri E, Kandarakis HA, Douzinas EE, Creatsas G, Kalofoutis A 2006 Short-term effect of orlistat on dietary glycotoxins in healthy women and women with polycystic ovary syndrome. Metabolism 55:494-500

  30. Doi SA, Al-Zaid M, Towers PA, Scott CJ, Al-Shoumer KA 2005 Ovarian steroids modulate neuroendocrine dysfunction in polycystic ovary syndrome. J Endocrinol Invest 28:882-892

  31. Douglas CC, Gower BA, Darnell BE, Ovalle F, Oster RA, Azziz R 2006 Role of diet in the treatment of polycystic ovary syndrome. Fertil Steril 85:679-688

  32. Duleba AJ, Banaszewska B, Spaczynski RZ, Pawelczyk L 2006 Simvastatin improves biochemical parameters in women with polycystic ovary syndrome: results of a prospective, randomized trial. Fertil Steril 85:996-1001

  33. Ehrmann DA, Liljenquist DR, Kasza K, Azziz R, Legro RS, Ghazzi MN 2006 Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab 91:48-53

  34. Eisenhardt S, Schwarzmann N, Henschel V, Germeyer A, von Wolff M, Hamann A, Strowitzki T 2006 Early effects of metformin in women with polycystic ovary syndrome: a prospective randomized, double-blind, placebo-controlled trial. J Clin Endocrinol Metab 91:946-952

  35. Elnashar A, Abdelmageed E, Fayed M, Sharaf M 2006 Clomiphene citrate and dexamethazone in treatment of clomiphene citrate-resistant polycystic ovary syndrome: a prospective placebo-controlled study. Hum Reprod

  36. Elnashar A, Fouad H, Eldosoky M, Saeid N 2006 Letrozole induction of ovulation in women with clomiphene citrate-resistant polycystic ovary syndrome may not depend on the period of infertility, the body mass index, or the luteinizing hormone/follicle-stimulating hormone ratio. Fertil Steril 85:511-513

  37. Elsenbruch S, Benson S, Hahn S, Tan S, Mann K, Pleger K, Kimmig R, Janssen OE 2006 Determinants of emotional distress in women with polycystic ovary syndrome. Hum Reprod 21:1092-1099

  38. Ferrero S, Anserini P, Remorgida V, Bentivoglio G, Ragni N 2006 Total and active ghrelin levels in women with polycystic ovary syndrome. Hum Reprod 21:565

  39. Florez JC 2005 Genetic susceptibility for polycystic ovary syndrome on chromosome 19: advances in the genetic dissection of complex reproductive traits. J Clin Endocrinol Metab 90:6732-6734

  40. Foong SC, Abbott DH, Zschunke MA, Lesnick TG, Phy JL, Dumesic DA 2006 Follicle Luteinization in Hyperandrogenic Follicles of Polycystic Ovary Syndrome (PCOS) Patients Undergoing Gonadotropin Therapy For In Vitro Fertilization (IVF). J Clin Endocrinol Metab

  41. Franks S 2006 Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: in defense of the Rotterdam criteria. J Clin Endocrinol Metab 91:786-789

  42. Franks S, McCarthy MI, Hardy K 2006 Development of polycystic ovary syndrome: involvement of genetic and environmental factors. Int J Androl 29:278-285; discussion 286-290

  43. Gambineri A, Vicennati V, Genghini S, Tomassoni F, Pagotto U, Pasquali R, Walker BR 2006 GENETIC VARIATION IN 11{beta}-HYDROXYSTEROID DEHYDROGENASE TYPE 1 PREDICTS ADRENAL HYPERANDROGENISM AMONGST LEAN WOMEN WITH POLYCYSTIC OVARY SYNDROME. J Clin Endocrinol Metab

  44. Garmes HM, Tambascia MA, Zantut-Wittmann DE 2005 Endocrine-metabolic effects of the treatment with pioglitazonein obese patients with polycystic ovary syndrome. Gynecol Endocrinol 21:317-323

  45. Genazzani AD, Strucchi C, Luisi M, Casarosa E, Lanzoni C, Baraldi E, Ricchieri F, Mehmeti H, Genazzani AR 2006 Metformin administration modulates neurosteroids secretion in non-obese amenorrhoic patients with polycystic ovary syndrome. Gynecol Endocrinol 22:36-43

  46. Glueck CJ, Golnik KC, Goldenberg N, Sieve L, Wang P 2005 Response to diet and metformin in women with idiopathic intracranial hypertension with and without concurrent polycystic ovary syndrome or hyperinsulinemia. MedGenMed 7:41

  47. Glueck CJ, Morrison JA, Friedman LA, Goldenberg N, Stroop DM, Wang P 2006 Obesity, free testosterone, and cardiovascular risk factors in adolescents with polycystic ovary syndrome and regularly cycling adolescents. Metabolism 55:508-514

  48. Glueck CJ, Sieve L, Zhu B, Wang P 2006 Plasminogen activator inhibitor activity, 4G5G polymorphism of the plasminogen activator inhibitor 1 gene, and first-trimester miscarriage in women with polycystic ovary syndrome. Metabolism 55:345-352

  49. Gonzalez A, Saez ME, Aragon MJ, Galan JJ, Vettori P, Molina L, Rubio C, Real LM, Ruiz A, Ramirez-Lorca R 2006 Specific haplotypes of the CALPAIN-5 gene are associated with polycystic ovary syndrome. Hum Reprod 21:943-951

  50. Gonzalez F, Rote NS, Minium J, Kirwan JP 2006 Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome. J Clin Endocrinol Metab 91:336-340

  51. Gonzalez F, Rote NS, Minium J, Kirwan JP 2006 Increased activation of nuclear factor kappaB triggers inflammation and insulin resistance in polycystic ovary syndrome. J Clin Endocrinol Metab 91:1508-1512

  52. Hahn S, Benson S, Elsenbruch S, Pleger K, Tan S, Mann K, Schedlowski M, van Halteren WB, Kimmig R, Janssen OE 2006 Metformin treatment of polycystic ovary syndrome improves health-related quality-of-life, emotional distress and sexuality. Hum Reprod

  53. Hahn S, Haselhorst U, Quadbeck B, Tan S, Kimmig R, Mann K, Janssen OE 2006 Decreased soluble leptin receptor levels in women with polycystic ovary syndrome. Eur J Endocrinol 154:287-294

  54. Hahn S, Janssen OE, Tan S, Pleger K, Mann K, Schedlowski M, Kimmig R, Benson S, Balamitsa E, Elsenbruch S 2005 Clinical and psychological correlates of quality-of-life in polycystic ovary syndrome. Eur J Endocrinol 153:853-860

  55. Hasan JA, Memon GU 2005 Impact of metformin therapy in patients with polycystic ovarian syndrome. J Coll Physicians Surg Pak 15:712-715

  56. Hawthorne G 2006 Metformin use and diabetic pregnancy-has its time come? Diabet Med 23:223-227

  57. Hayden BJ, Balen AH 2006 The role of the central nervous system in the pathogenesis of polycystic ovary syndrome. Minerva Ginecol 58:41-54

  58. Heijnen EM, Eijkemans MJ, Hughes EG, Laven JS, Macklon NS, Fauser BC 2006 A meta-analysis of outcomes of conventional IVF in women with polycystic ovary syndrome. Hum Reprod Update 12:13-21

  59. Iatrakis G, Tsionis C, Adonakis G, Stoikidou M, Anthouli-Anagnostopoulou F, Parava M, Vouxinou A, Georgopoulos NA, Kourounis G 2006 Polycystic ovarian syndrome, insulin resistance and thickness of the endometrium. Eur J Obstet Gynecol Reprod Biol

  60. Ibanez L, de Zegher F 2006 Low-dose flutamide-metformin therapy for hyperinsulinemic hyperandrogenism in non-obese adolescents and women. Hum Reprod Update 12:243-252

  61. Inal MM, Yildirim Y, Taner CE 2005 Comparison of the clinical efficacy of flutamide and spironolactone plus Diane 35 in the treatment of idiopathic hirsutism: a randomized controlled study. Fertil Steril 84:1693-1697

  62. Jahanfar S, Maleki H, Mosavi AR 2005 Subclinical eating disorder, polycystic ovary syndrome- is there any connection between these two conditions through leptin- a twin study. Med J Malaysia 60:441-446

  63. Kaaja RJ, Poyhonen-Alho MK 2006 Insulin resistance and sympathetic overactivity in women. J Hypertens 24:131-141

  64. Kauffman RP, Baker VM, DiMarino P, Castracane VD 2006 Hyperinsulinemia and circulating dehydroepiandrosterone sulfate in white and Mexican American women with polycystic ovary syndrome. Fertil Steril 85:1010-1016

  65. Khorram O, Helliwell JP, Katz S, Bonpane CM, Jaramillo L 2006 Two weeks of metformin improves clomiphene citrate-induced ovulation and metabolic profiles in women with polycystic ovary syndrome. Fertil Steril

  66. Klipstein KG, Goldberg JF 2006 Screening for bipolar disorder in women with polycystic ovary syndrome: A pilot study. J Affect Disord 91:205-209

  67. Kolbus A, Walch K, Szabo L, Huber JC, Nagele F, Unfried G 2006 A polymorphism of the interleukin 1 receptor antagonist is not associated with polycystic ovary syndrome in Caucasian women. Fertil Steril 85:523-525

  68. Koren G, Gilbert C, Valois M 2006 Metformin use during the first trimester of pregnancy. Is it safe? Can Fam Physician 52:171-172

  69. Kousta E, Tolis G, Franks S 2005 Polycystic ovary syndrome. Revised diagnostic criteria and long-term health consequences. Hormones (Athens Greece) 4:133-147

  70. Lakhani K, Yang W, Dooley A, El-Mahdi E, Sundaresan M, McLellan S, Bruckdorfer R, Leonard A, Seifalian A, Hardiman P 2006 Aortic function is compromised in a rat model of polycystic ovary syndrome. Hum Reprod 21:651-656

  71. Lane DE 2006 Polycystic ovary syndrome and its differential diagnosis. Obstet Gynecol Surv 61:125-135

  72. Laredo SE 2006 Obesity, polycystic ovary syndrome, infertility treatment: asking obese women to lose weight before treatment increases stigmatisation. Bmj 332:609

  73. Leibel NI, Baumann EE, Kocherginsky M, Rosenfield RL 2006 Relationship of adolescent polycystic ovary syndrome to parental metabolic syndrome. J Clin Endocrinol Metab 91:1275-1283

  74. Lemay A, Dodin S, Turcot L, Dechene F, Forest JC 2006 Rosiglitazone and ethinyl estradiol/cyproterone acetate as single and combined treatment of overweight women with polycystic ovary syndrome and insulin resistance. Hum Reprod 21:121-128

  75. Lewandowski KC, Komorowski J, O'Callaghan CJ, Tan BK, Chen J, Prelevic GM, Randeva HS 2006 Increased circulating levels of matrix metalloproteinase-2 and -9 in women with the polycystic ovary syndrome. J Clin Endocrinol Metab 91:1173-1177

  76. Lo JC, Feigenbaum SL, Yang J, Pressman AR, Selby JV, Go AS 2006 Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome. J Clin Endocrinol Metab 91:1357-1363

  77. Lord JM, Norman R 2006 Obesity, polycystic ovary syndrome, infertility treatment: lifestyle modification is paramount. Bmj 332:609

  78. Luque-Ramirez M, San Millan JL, Escobar-Morreale HF 2006 Genomic variants in polycystic ovary syndrome. Clin Chim Acta 366:14-26

  79. Maher JF, Hines RS, Futterweit W, Crawford S, Lu D, Shen P, Oefner P, Kazi M, Wilson JG, Subauste JS, Cowan BD 2005 FEM1A is a candidate gene for polycystic ovary syndrome. Gynecol Endocrinol 21:330-335

  80. Marshall JC 2006 Obesity in adolescent girls: is excess androgen the real bad actor? J Clin Endocrinol Metab 91:393-395

  81. Mastorakos G, Koliopoulos C, Deligeoroglou E, Diamanti-Kandarakis E, Creatsas G 2006 Effects of two forms of combined oral contraceptives on carbohydrate metabolism in adolescents with polycystic ovary syndrome. Fertil Steril 85:420-427

  82. McDonough PG 2006 How many of the items in the polycystic ovary syndrome can be validated statistically? Fertil Steril 85:530-531

  83. Mohlig M, Spranger J, Ristow M, Pfeiffer AF, Schill T, Schlosser HW, Moltz L, Brabant G, Schofl C 2006 Predictors of abnormal glucose metabolism in women with polycystic ovary syndrome. Eur J Endocrinol 154:295-301

  84. Mulders AG, ten Kate-Booij M, Pal R, De Kruif M, Nekrui L, Oostra BA, Fauser BC, Laven JS 2005 Influence of oral contraceptive pills on phenotype expression in women with polycystic ovary syndrome. Reprod Biomed Online 11:690-696

  85. Ng EH, Chan CC, Ho PC 2006 Are there differences in ultrasound parameters between Chinese women with polycystic ovaries only and with polycystic ovary syndrome? Eur J Obstet Gynecol Reprod Biol 125:92-98

  86. Ornstein RM, Jacobson MS, Copperman NM 2006 2: Weight loss improves body composition and menstrual function in adolescents with polycystic ovary syndrome. J Adolesc Health 38:100-101

  87. Owj M, Tehrani-Nejad ES, Amirchaghmaghi E, Baghestani AR, Ahmadi J 2005 The role of ketoconazole in the prevention of ovarian hyperstimulation syndrome in patients with polycystic ovary syndrome during assisted reproductive technology cycles. Saudi Med J 26:1584-1587

  88. Pagan YL, Srouji SS, Jimenez Y, Emerson A, Gill S, Hall JE 2006 Inverse relationship between luteinizing hormone and body mass index in polycystic ovarian syndrome: investigation of hypothalamic and pituitary contributions. J Clin Endocrinol Metab 91:1309-1316

  89. Palomba S, Orio F, Jr., Falbo A, Russo T, Caterina G, Manguso F, Tolino A, Colao A, Zullo F 2005 Metformin administration and laparoscopic ovarian drilling improve ovarian response to clomiphene citrate (CC) in oligo-anovulatory CC-resistant women with polycystic ovary syndrome. Clin Endocrinol (Oxf) 63:631-635

  90. Palomba S, Russo T, Orio F, Jr., Falbo A, Manguso F, Cascella T, Tolino A, Carmina E, Colao A, Zullo F 2006 Uterine effects of metformin administration in anovulatory women with polycystic ovary syndrome. Hum Reprod 21:457-465

  91. Palomba S, Zullo F 2006 Ovulation induction in infertile patients with polycystic ovary syndrome. Minerva Ginecol 58:115-135

  92. Panidis D, Macut D, Farmakiotis D, Rousso D, Kourtis A, Katsikis I, Spanos N, Petakov M, Bjekic J, Damjanovic S 2006 Indices of insulin sensitivity, beta cell function and serum proinsulin levels in the polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol

  93. Patel SM, Nestler JE 2006 Fertility in polycystic ovary syndrome. Endocrinol Metab Clin North Am 35:137-155, vii

  94. Paul S, Smith L 2005 The metabolic syndrome in women: a growing problem for cardiac risk. J Cardiovasc Nurs 20:427-432

  95. Pillay OC, Te Fong LF, Crow JC, Benjamin E, Mould T, Atiomo W, Menon PA, Leonard AJ, Hardiman P 2006 The association between polycystic ovaries and endometrial cancer. Hum Reprod 21:924-929

  96. Qin K, Ehrmann DA, Cox N, Refetoff S, Rosenfield RL 2006 Identification of a functional polymorphism of the human type 5 17beta-hydroxysteroid dehydrogenase gene associated with polycystic ovary syndrome. J Clin Endocrinol Metab 91:270-276

  97. Rautio K, Tapanainen JS, Ruokonen A, Morin-Papunen LC 2006 Endocrine and metabolic effects of rosiglitazone in overweight women with PCOS: a randomized placebo-controlled study. Hum Reprod

  98. Reaven GM 2005 Insulin resistance, the insulin resistance syndrome, and cardiovascular disease. Panminerva Med 47:201-210

  99. Rouzi AA, Ardawi MS 2006 A randomized controlled trial of the efficacy of rosiglitazone and clomiphene citrate versus metformin and clomiphene citrate in women with clomiphene citrate-resistant polycystic ovary syndrome. Fertil Steril 85:428-435

  100. Setji TL, Holland ND, Sanders LL, Pereira KC, Mae Diehl A, Brown AJ 2006 Nonalcoholic steatohepatitis and nonalcoholic fatty liver disease in young women with polycystic ovary syndrome. J Clin Endocrinol Metab

  101. Shibahara H, Hirano Y, Kikuchi K, Suzuki T, Takamizawa S, Suzuki M 2006 Postoperative endocrine alterations and clinical outcome of infertile women with polycystic ovary syndrome after transvaginal hydrolaparoscopic ovarian drilling. Fertil Steril 85:244-246

  102. Sir-Petermann T 2005 Polycystic ovary syndrome, a pathway to type 2 diabetes. Nutrition 21:1160-1163

  103. Snyder BS 2005 Polycystic ovary syndrome (PCOS) in the adolescent patient: recommendations for practice. Pediatr Nurs 31:416-421

  104. Starka L, Duskova M, Cermakova I, Vrbikova J, Hill M 2005 Premature androgenic alopecia and insulin resistance. Male equivalent of polycystic ovary syndrome? Endocr Regul 39:127-131

  105. Tan S, Hahn S, Janssen OE 2005 Insulin resistance syndrome and polycystic ovary syndrome: implications for diagnosis and treatment. Panminerva Med 47:211-217

  106. Tang T, Glanville J, Hayden CJ, White D, Barth JH, Balen AH 2006 Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study. Hum Reprod 21:80-89

  107. Tang T, Glanville J, Orsi N, J HB, A HB 2006 The use of metformin for women with PCOS undergoing IVF treatment. Hum Reprod

  108. Tasali E, Van Cauter E, Ehrmann DA 2006 Relationships between sleep disordered breathing and glucose metabolism in polycystic ovary syndrome. J Clin Endocrinol Metab 91:36-42

  109. Thatcher SS, Jackson EM 2006 Pregnancy outcome in infertile patients with polycystic ovary syndrome who were treated with metformin. Fertil Steril 85:1002-1009

  110. Tingthanatikul Y, Choktanasiri W, Rochanawutanon M, Weerakeit S 2006 Prevalence and clinical predictors of endometrial hyperplasiain anovulatory women presenting with amenorrhea. Gynecol Endocrinol 22:101-105

  111. Topcu S, Caliskan M, Ozcimen EE, Tok D, Uckuyu A, Erdogan D, Gullu H, Yildirir A, Zeyneloglu H, Muderrisoglu H 2006 Do young women with polycystic ovary syndrome show early evidence of preclinical coronary artery disease? Hum Reprod 21:930-935

  112. Vambergue A, Lautier C, Valat AS, Cortet-Rudelli C, Grigorescu F, Dewailly D 2006 Follow-up study of two sisters with type A syndrome of severe insulin resistance gives a new insight into PCOS pathogenesis in relation to puberty and pregnancy outcome: a case report. Hum Reprod 21:1274-1278

  113. Vanky E, Salvesen KA, Hjorth-Hansen H, Bjerve K, Carlsen SM 2006 Beneficial effect of metformin on pregnancy outcome in women with polycystic ovary syndrome is not associated with major changes in C-reactive protein levels or indices of coagulation. Fertil Steril 85:770-774

  114. Vrtacnik-Bokal E, Meden-Vrtovec H, Verdenik I 2006 Uterine arterial blood flow and the substances of ovarian renin-angiotensin system in women with polycystic ovaries undergoing in vitro fertilization. Eur J Obstet Gynecol Reprod Biol 124:77-81

  115. Xita N, Tsatsoulis A 2006 Fetal Programming of Polycystic Ovary Syndrome by Androgen Excess: Evidence from Experimental, Clinical and Genetic Association Studies. J Clin Endocrinol Metab

  116. Yao LQ, Kuang JQ, Feng YJ, Yang DZ, Li L, Xu CJ 2006 Characterization of unilateral polycystic ovary compared with polycystic ovary syndrome. Fertil Steril 85:805-808

  117. Yilmaz M, Biri A, Karakoc A, Toruner F, Bingol B, Cakir N, Tiras B, Ayvaz G, Arslan M 2005 The effects of rosiglitazone and metformin on insulin resistance and serum androgen levels in obese and lean patients with polycystic ovary syndrome. J Endocrinol Invest 28:1003-1008

  118. Yoo RY, Dewan A, Basu R, Newfield R, Gottschalk M, Chang RJ 2006 Increased luteinizing hormone pulse frequency in obese oligomenorrheic girls with no evidence of hyperandrogenism. Fertil Steril 85:1049-1056

  119. Zafar S 2005 Role of metformin in correcting hyperinsulinemia, menstrual irregularity and anovulation in polycystic ovary syndrome. J Ayub Med Coll Abbottabad 17:54-56

  120. Zulian E, Sartorato P, Schiavi F, Moghetti P, Castello R, Mantero F, Opocher G, Scaroni C 2005 The M235T polymorphism of the angiotensinogen gene in women with polycystic ovary syndrome. Fertil Steril 84:1520-1521